Chugai Pharmaceutical Co Stock Market Value

CHGCF Stock  USD 39.14  2.42  5.82%   
Chugai Pharmaceutical's market value is the price at which a share of Chugai Pharmaceutical trades on a public exchange. It measures the collective expectations of Chugai Pharmaceutical Co investors about its performance. Chugai Pharmaceutical is trading at 39.14 as of the 29th of March 2024. This is a -5.82 percent down since the beginning of the trading day. The stock's lowest day price was 39.14.
With this module, you can estimate the performance of a buy and hold strategy of Chugai Pharmaceutical Co and determine expected loss or profit from investing in Chugai Pharmaceutical over a given investment horizon. Check out Chugai Pharmaceutical Correlation, Chugai Pharmaceutical Volatility and Chugai Pharmaceutical Alpha and Beta module to complement your research on Chugai Pharmaceutical.
Symbol

Please note, there is a significant difference between Chugai Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Chugai Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chugai Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Chugai Pharmaceutical 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Chugai Pharmaceutical's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Chugai Pharmaceutical.
0.00
02/28/2024
No Change 0.00  0.0 
In 30 days
03/29/2024
0.00
If you would invest  0.00  in Chugai Pharmaceutical on February 28, 2024 and sell it all today you would earn a total of 0.00 from holding Chugai Pharmaceutical Co or generate 0.0% return on investment in Chugai Pharmaceutical over 30 days. Chugai Pharmaceutical is related to or competes with Acco Brands, RBC Bearings, Weyco, Franklin Wireless, GlucoTrack, BBB Foods, and MYT Netherlands. Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, sa... More

Chugai Pharmaceutical Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Chugai Pharmaceutical's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Chugai Pharmaceutical Co upside and downside potential and time the market with a certain degree of confidence.

Chugai Pharmaceutical Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Chugai Pharmaceutical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Chugai Pharmaceutical's standard deviation. In reality, there are many statistical measures that can use Chugai Pharmaceutical historical prices to predict the future Chugai Pharmaceutical's volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Chugai Pharmaceutical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
36.7239.1441.56
Details
Intrinsic
Valuation
LowRealHigh
29.3831.8043.05
Details
Naive
Forecast
LowNextHigh
32.2834.7037.12
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
35.9040.4244.94
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Chugai Pharmaceutical. Your research has to be compared to or analyzed against Chugai Pharmaceutical's peers to derive any actionable benefits. When done correctly, Chugai Pharmaceutical's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Chugai Pharmaceutical.

Chugai Pharmaceutical Backtested Returns

We consider Chugai Pharmaceutical very steady. Chugai Pharmaceutical secures Sharpe Ratio (or Efficiency) of 0.0491, which signifies that the company had a 0.0491% return per unit of risk over the last 3 months. We have found twenty-one technical indicators for Chugai Pharmaceutical Co, which you can use to evaluate the volatility of the firm. Please confirm Chugai Pharmaceutical's Risk Adjusted Performance of 0.0348, mean deviation of 0.7469, and Standard Deviation of 2.42 to double-check if the risk estimate we provide is consistent with the expected return of 0.12%. Chugai Pharmaceutical has a performance score of 3 on a scale of 0 to 100. The firm shows a Beta (market volatility) of -0.073, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Chugai Pharmaceutical are expected to decrease at a much lower rate. During the bear market, Chugai Pharmaceutical is likely to outperform the market. Chugai Pharmaceutical right now shows a risk of 2.44%. Please confirm Chugai Pharmaceutical skewness, as well as the relationship between the rate of daily change and price action indicator , to decide if Chugai Pharmaceutical will be following its price patterns.

Auto-correlation

    
  -0.82  

Excellent reverse predictability

Chugai Pharmaceutical Co has excellent reverse predictability. Overlapping area represents the amount of predictability between Chugai Pharmaceutical time series from 28th of February 2024 to 14th of March 2024 and 14th of March 2024 to 29th of March 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Chugai Pharmaceutical price movement. The serial correlation of -0.82 indicates that around 82.0% of current Chugai Pharmaceutical price fluctuation can be explain by its past prices.
Correlation Coefficient-0.82
Spearman Rank Test-0.59
Residual Average0.0
Price Variance1.45

Chugai Pharmaceutical lagged returns against current returns

Autocorrelation, which is Chugai Pharmaceutical pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Chugai Pharmaceutical's pink sheet expected returns. We can calculate the autocorrelation of Chugai Pharmaceutical returns to help us make a trade decision. For example, suppose you find that Chugai Pharmaceutical has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Chugai Pharmaceutical regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Chugai Pharmaceutical pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Chugai Pharmaceutical pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Chugai Pharmaceutical pink sheet over time.
   Current vs Lagged Prices   
       Timeline  

Chugai Pharmaceutical Lagged Returns

When evaluating Chugai Pharmaceutical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Chugai Pharmaceutical pink sheet have on its future price. Chugai Pharmaceutical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Chugai Pharmaceutical autocorrelation shows the relationship between Chugai Pharmaceutical pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Chugai Pharmaceutical Co.
   Regressed Prices   
       Timeline  

Pair Trading with Chugai Pharmaceutical

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chugai Pharmaceutical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chugai Pharmaceutical will appreciate offsetting losses from the drop in the long position's value.

Moving against Chugai Pink Sheet

  0.65PTAIF PT Astra InternationalPairCorr
  0.48NVSEF Novartis AGPairCorr
  0.43TLK Telkom Indonesia Tbk Financial Report 26th of April 2024 PairCorr
The ability to find closely correlated positions to Chugai Pharmaceutical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Chugai Pharmaceutical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Chugai Pharmaceutical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Chugai Pharmaceutical Co to buy it.
The correlation of Chugai Pharmaceutical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Chugai Pharmaceutical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Chugai Pharmaceutical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Chugai Pharmaceutical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Chugai Pharmaceutical Correlation, Chugai Pharmaceutical Volatility and Chugai Pharmaceutical Alpha and Beta module to complement your research on Chugai Pharmaceutical.
Note that the Chugai Pharmaceutical information on this page should be used as a complementary analysis to other Chugai Pharmaceutical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Complementary Tools for Chugai Pink Sheet analysis

When running Chugai Pharmaceutical's price analysis, check to measure Chugai Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chugai Pharmaceutical is operating at the current time. Most of Chugai Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Chugai Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chugai Pharmaceutical's price. Additionally, you may evaluate how the addition of Chugai Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Chugai Pharmaceutical technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
A focus of Chugai Pharmaceutical technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Chugai Pharmaceutical trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...